SNDX: Syndax Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SNDX: Syndax Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 919.85
Enterprise Value ($M) 1,109.65
Book Value ($M) 215.06
Book Value / Share 2.50
Price / Book 4.28
NCAV ($M) 123.10
NCAV / Share 1.43
Price / NCAV 7.47

Profitability (mra)
Return on Invested Capital (ROIC) -0.59
Return on Assets (ROA) -0.61
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 5.73
Current Ratio 5.80

Balance Sheet (mrq) ($M)
Current Assets 548.75
Assets 640.71
Liabilities 425.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 23.68
Operating Income -339.67
Net Income -318.76
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -274.90
Cash from Investing -219.78
Cash from Financing 353.37

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
1 day ago 13G/A Goldman Sachs Group Inc 5.20 -24.23
3 days ago 13G/A Morgan Stanley 2.40 -61.96
04-17 13G/A BlackRock, Inc. 7.80 -23.26
03-07 13G/A Wellington Management Group Llp 0.00 -99.28
02-14 13G/A Kynam Capital Management, LP 9.98 50.53
01-22 13G Point72 Asset Management, L.P. 5.00 50.92
10-18 13G/A State Street Corp 4.40 -24.83

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-03 10-K 6884,826,632 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 350,111 1,944,280 18.01
2025-05-08 493,227 3,174,728 15.54
2025-05-07 512,498 3,704,919 13.83
2025-05-06 1,123,685 7,388,579 15.21
2025-05-05 1,358,403 3,903,270 34.80

(click for more detail)

Similar Companies
SDGR – Schrödinger, Inc. SLDB – Solid Biosciences Inc.
SLRN – Acelyrin, Inc. SPRO – Spero Therapeutics, Inc.
SRPT – Sarepta Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io